Natural History of Type 1 Interferonopathies: Insights From a European Cohort

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

May 31, 2045

Study Completion Date

May 31, 2045

Conditions
Genetic DiseaseImmune DysfunctionNeurological Diseases or ConditionsAutoimmune Diseases
Trial Locations (16)

21231

NOT_YET_RECRUITING

CHU de Dijon, Dijon

25030

NOT_YET_RECRUITING

CHU de Besançon, Besançon

29200

NOT_YET_RECRUITING

CHU Morvan, Brest

31300

NOT_YET_RECRUITING

Hôpital des Enfants - CHU de Toulouse, Toulouse

34295

NOT_YET_RECRUITING

CHU de Montepellier, Montpellier

44000

NOT_YET_RECRUITING

CHU de Nantes, Nantes

47600

NOT_YET_RECRUITING

CH Agen-Nérac, Nérac

57530

NOT_YET_RECRUITING

Hôpital de Mercy - CHR Metz Thionville, Ars-Laquenexy

69400

NOT_YET_RECRUITING

Hôpitaux Nord Ouest Villefranche, Gleizé

69500

NOT_YET_RECRUITING

Hôpital Femme Mère Enfant - HCL, Bron

75012

NOT_YET_RECRUITING

Hôpital Armand Trousseau, Paris

75015

RECRUITING

Hôpital Necker Enfants Malades, Paris

75018

NOT_YET_RECRUITING

Hôpital Bichat, Paris

75019

NOT_YET_RECRUITING

Hôpital Robert Debré, Paris

Unknown

NOT_YET_RECRUITING

Hôpital Claude Huriez, CHU de Lille, Lille

06200

NOT_YET_RECRUITING

Hôpital de l'Archet, Nice

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Imagine Institute

OTHER